Pathophysiological Response to Hypoxia — From the Molecular Mechanisms of Malady to Drug Discovery:Hypoxia-Inducible Factor-1 (HIF-1)-Active Cells as a Target for Cancer Therapy

スポンサーリンク

概要

• 論文の詳細を見る

• The microenvironment of solid tumors is characterized by low pO2 that is well below physiological levels. Intratumoral hypoxia is a major factor contributing to cancer progression and is exacerbated as a result of oxygen consumption by rapidly proliferating tumor cells near blood vessels, poor lymphatic drainage resulting in high interstitial pressure, and irregular blood supply through immature tumor vasculature. Hypoxia-inducible factor-1 (HIF-1) is the main transcription factor that regulates cellular responses to hypoxia. Cellular changes induced by HIF-1 are extremely important targets for cancer therapy. Therefore, targeting strategies to counteract HIF-1–active cells are essential for cancer therapy. In this study, we introduce a novel strategy for targeting HIF-1–active cells.

• 社団法人 日本薬理学会の論文

著者

• Kizaka-Kondoh Shinae

  Department of Biomolecular Engineering, Tokyo Institute of Technology Graduate School of Bioscience

• Kuchimaru Takahiro

  Department of Biomolecular Engineering, Tokyo Institute of Technology Graduate School of Bioscience

• Kadonosono Tetsuya

  Department of Biomolecular Engineering, Tokyo Institute of Technology Graduate School of Bioscience

• Kuchimaru Takahiro

  Department Of Biomolecular Engineering Tokyo Institute Of Technology Graduate School Of Bioscience A

関連論文

• Pathophysiological Response to Hypoxia — From the Molecular Mechanisms of Malady to Drug Discovery:Hypoxia-Inducible Factor-1 (HIF-1)-Active Cells as a Target for Cancer Therapy
• Pathophysiological Response to Hypoxia-From the Molecular Mechanisms of Malady to Drug Discovery : Hypoxia-Inducible Factor-1 (HIF-1)-Active Cells as a Target for Cancer Therapy

スポンサーリンク